C12N 2760/00
Ssrna viruses negative-sense
Official title: ssRNA viruses negative-sense
C12N2760/00 (Ssrna viruses negative-sense) appears on 4,339 US grants and 6,582 published applications in this corpus.
Search patents in C12N- Granted patents
- 4,339
- Published applications
- 6,582
- Assignees
- 2,219
- Inventors
- 9,855
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 13 | 0 |
| 1977 | 8 | 0 |
| 1978 | 7 | 0 |
| 1979 | 7 | 0 |
| 1980 | 10 | 0 |
| 1981 | 8 | 0 |
| 1982 | 14 | 0 |
| 1983 | 2 | 0 |
| 1984 | 4 | 0 |
| 1985 | 14 | 0 |
| 1986 | 13 | 0 |
| 1987 | 17 | 0 |
| 1988 | 13 | 0 |
| 1989 | 7 | 0 |
| 1990 | 2 | 0 |
| 1991 | 17 | 0 |
| 1992 | 21 | 0 |
| 1993 | 19 | 0 |
| 1994 | 15 | 0 |
| 1995 | 14 | 0 |
| 1996 | 27 | 0 |
| 1997 | 56 | 0 |
| 1998 | 96 | 0 |
| 1999 | 75 | 0 |
| 2000 | 87 | 0 |
| 2001 | 81 | 18 |
| 2002 | 71 | 83 |
| 2003 | 72 | 154 |
| 2004 | 70 | 162 |
| 2005 | 48 | 147 |
| 2006 | 59 | 142 |
| 2007 | 70 | 168 |
| 2008 | 68 | 184 |
| 2009 | 96 | 225 |
| 2010 | 103 | 306 |
| 2011 | 99 | 274 |
| 2012 | 108 | 269 |
| 2013 | 131 | 267 |
| 2014 | 172 | 310 |
| 2015 | 203 | 271 |
| 2016 | 212 | 309 |
| 2017 | 233 | 320 |
| 2018 | 238 | 312 |
| 2019 | 249 | 327 |
| 2020 | 240 | 313 |
| 2021 | 212 | 314 |
| 2022 | 216 | 361 |
| 2023 | 198 | 369 |
| 2024 | 197 | 429 |
| 2025 | 220 | 321 |
| 2026 | 107 | 227 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Mutant influenza B/Victoria lineage virus hemagglutinin proteins6 Oct 2026US 12,752,001 B2ModernaTX, Inc.
- Antiviral structurally-stabilized Ebolavirus peptides and uses thereof6 Oct 2026US 12,753,208 B2Dana-Farber Cancer Institute, Inc.
- Oncolytic virus in combination with immune checkpoint inhibitor for treating tumors15 Sep 2026US 12,734,202 B2Joint Biosciences (Sh) Ltd.
- Cell culture process for producing RSV F protein15 Sep 2026US 12,734,231 B2Pfizer Inc.
- Virus-like particles containing CST1 protein and toxoplasma vaccine using same1 Sep 2026US 12,721,886 B2University-Industry Cooperation Group of Kyung Hee University
- Differential coating of microprojections and microneedles on arrays8 Oct 2026US 2026/0306611 A1Vaxxas Pty Limited
- Prefusion-stabilized human parainfluenza virus 3 f proteins8 Oct 2026US 2026/0306613 A1Board of Regents, The University of Texas System
- Purification of viruses and viral like particles8 Oct 2026US 2026/0308616 A1Interius Biotherapeutics, Inc.
- Cell surface engineered of tailored therapeutic gene delivery8 Oct 2026US 2026/0308617 A1The Children’s Hospital of Philadelphia
- Influenza ehead immunogens1 Oct 2026US 2026/0295029 A1The Scripps Research Institute
Most cited
By later US patents
- Vector and method of use for nucleic acid delivery to non-dividing cells323US 6,013,516 AThe Salk Institute for Biological Studies · 2000
- Modified vaccinia virus298US 4,603,112 AHealth Research, Inc. · 1986
- Frozen piercing implements and methods for piercing a substrate284US 8,784,385 B2The Invention Science Fund I, LLC · 2014
- Modified vaccinia virus and methods for making and using the same264US 4,769,330 AHealth Research, Inc. · 1988
- Composition for introducing nucleic acid complexes into higher eucaryotic cells257US 5,547,932 ABoehringer Ingelheim International GmbH · 1996